Android Apple

Is Passage Bio (NASDAQ:PASG) In A Good Position To Invest In Growth?

By Yahoo! Finance   |   5 months ago
Is Passage Bio (NASDAQ:PASG) In A Good Position To Invest In Growth?

Although some unprofitable businesses like Salesforce.com have seen success, others like Pets.com have failed. Passage Bio shareholders may be concerned about its cash burn, with 17 months of cash runway as of March 2024.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.